|
1
|
Bennett MR, Piyaphanee N, Czech K,
Mitsnefes M and Devarajan P: NGAL distinguishes steroid sensitivity
in idiopathic nephrotic syndrome. Pediatr Nephrol. 27:807–812.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Suzuki Y and Sato S: Secondary
osteoporosis UPDATE. Clinical significance of
glucocorticoid-induced osteoporosis. Clin Calcium. 20:645–653.
2010.(In Japanese). PubMed/NCBI
|
|
3
|
Conradie MM, Cato AC, Ferris WF, de Wet H,
et al: MKP-1 knockout does not prevent glucocorticoid-induced bone
disease in mice. Calcif Tissue Int. 89:221–227. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chiodini I, Torlontano M, Carnevale V,
Trischitta V and Scillitani A: Skeletal involvement in adult
patients with endogenous hypercortisolism. J Endocrinol Invest.
31:267–276. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gustafson B, Eliasson B and Smith U:
Thiazolidinediones increase the wingless-type MMTV integration site
family (WNT) inhibitor Dickkopf-1 in adipocytes: A link with
osteogenesis. Diabetologia. 53:536–540. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Haniu M, Horan T, Spahr C, Hui J, Fan W,
Chen C, Richards WG and Lu HS: Human Dickkopf-1 (huDKK1) protein:
characterization of glycosylation and determination of disulfide
linkages in the two cysteine-rich domains. Protein Sci.
20:1802–1813. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guañabens N, Gifre L and Peris P: The role
of Wnt signaling and sclerostin in the pathogenesis of
glucocorticoid-induced osteoporosis. Curr Osteoporos Rep. 12:90–97.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guerrero F, Herencia C, Almadén Y,
Martínez-Moreno JM, de Montes Oca A, Rodriguez-Ortiz ME,
Diaz-Tocados JM, Canalejo A, Florio M, López I, et al: TGF-β
prevents phosphate-induced osteogenesis through inhibition of BMP
and Wnt/β-catenin pathways. PLoS One. 9:e891792014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mokhtar GM, Tantawy AA, Hamed AA, Adly AA,
Ismail EA and Makkeyah SM: Tartrate-resistant acid phosphatase 5b
in young patients with sickle cell disease and trait siblings:
Relation to vasculopathy and bone mineral density. Clin Appl Thromb
Hemost. Jul 06–2015.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lv Y, Wang G, Xu W, Tao P, Lv X and Wang
Y: Tartrate-resistant acid phosphatase 5b is a marker of osteoclast
number and volume in RAW 264.7 cells treated with
receptor-activated nuclear κB ligand. Exp Ther Med. 9:143–146.
2015.PubMed/NCBI
|
|
11
|
Nakanishi K, Iijima K, Ishikura K, Hataya
H, Nakazato H, Sasaki S, Honda M and Yoshikawa N: Japanese Study
Group of Renal Disease in Children: Two-year outcome of the ISKDC
regimen and frequent-relapsing risk in children with idiopathic
nephrotic syndrome. Clin J Am Soc Nephrol. 8:756–762. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gulati S, Godbole M, Singh U, Gulati K and
Srivastava A: Are children with idiopathic nephrotic syndrome at
risk for metabolic bone disease? Am J Kidney Dis. 41:1163–1169.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cheng FW, Monnat SM and Lohse B: Middle
school-aged child enjoyment of food tastings predicted interest in
nutrition education on osteoporosis prevention. J Sch Health.
85:467–476. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Baron R and Rawadi G: Targeting the
Wnt/beta-catenin pathway to regulate bone formation in the adult
skeleton. Endocrinology. 148:2635–2643. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Obrant KJ, Ivaska KK, Gerdhem P, Alatalo
SL, Pettersson K and Väänänen HK: Biochemical markers of bone
turnover are influenced by recently sustained fracture. Bone.
36:786–792. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee S, Chung CK, Oh SH and Park SB:
Correlation between bone mineral density measured by dual-energy
X-ray absorptiometry and hounsfield units measured by diagnostic CT
in lumbar spine. J Korean Neurosurg Soc. 54:384–389. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gifre L, Vidal J, Carrasco JL, Filella X,
Ruiz-Gaspa S, Muxi A, Portell E, Monegal A, Guanabens N and Peris
P: Effect of recent spinal cord injury on wnt signaling antagonists
(sclerostin and dkk-1) and their relationship with bone loss. A
12-month prospective study. J Bone Miner Res. 30:1014–1021. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ogoshi T, Hagino H, Fukata S, Tanishima S,
Okano T and Teshima R: Influence of glucocorticoid on bone in 3-,
6-, and 12-month-old rats as determined by bone mass and
histomorphometry. Mod Rheumatol. 18:552–561. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kondo T, Kitazawa R, Yamaguchi A and
Kitazawa S: Dexamethasone promotes osteoclastogenesis by inhibiting
osteoprotegerin through multiple levels. J Cell Biochem.
103:335–345. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim HJ: New understanding of
glucocorticoid action in bone cells. BMB Rep. 43:524–529. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jaeger BA, Tauer JT, Ulmer A, Kuhlisch E,
Roth HJ and Suttorp M: Changes in bone metabolic parameters in
children with chronic myeloid leukemia on imatinib treatment. Med
Sci Monit. 18:CR721–CR728. 2012. View Article : Google Scholar : PubMed/NCBI
|
